Position in ADCT
as of Mar 31, 2026
· filed May 6, 2026
Position Value
$44,625
-$67,982 QoQ
Shares Held
11,900
-62.7% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ADCT Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026LPL Financial LLC holds $149,817,633 across 42 Drug Manufacturers - Specialty & Generic names. ADCT ranks #39 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
296,876 | $35,093,711 | |
| 2 | HLN |
Haleon plc
|
1,750,087 | $17,518,370 | |
| 3 | PRGO |
PERRIGO Co plc
|
1,330,730 | $14,292,040 | |
| 4 | ELAN |
Elanco Animal Health Inc
|
395,645 | $9,467,784 | |
| 5 | TAK |
Takeda Pharmaceutical Co Ltd
|
474,207 | $8,782,313 | |
| 6 | VTRS |
Viatris Inc
|
575,805 | $7,779,125 | |
| 7 | PAHC |
Phibro Animal Health Corp
|
129,157 | $7,143,673 | |
| 8 | UTHR |
UNITED THERAPEUTICS Corp
|
11,492 | $6,814,526 |
All Filings in ADCT
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $44,625 | 11,900 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $112,607 | 31,900 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $180,400 | 45,100 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $120,600 | 45,000 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $35,250 | 25,000 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $49,750 | 25,000 | Shares | Sole | 2025-02-11 | |
| No filing history on record for this holder in this stock. | ||||||